
Residency Essentials: Intrahepatic Cholangiocarcinoma and Hepatic metastatic disease
Intrahepatic Cholangiocarcinoma and Hepatic metastatic disease (colorectal cancer, neuroendocrine, lung)
This course is focused on the epidemiology, staging and therapeutic options for intrahepatic cholangiocarcinoma and liver dominant metastatic disease from colorectal or neuroendocrine carcinoma.
Expected completion time: 4 hours
Learning Objectives
- Recognize the staging of Colorectal and Neuroendocrine Carcinomas
- Discuss common treatment algorithms for these diseases
- Determine what patients are appropriate for locoregional therapy of liver dominant metastatic disease
- Discuss the differences in treatment options for intrahepatic vs extrahepatic cholangiocarcinoma
Course Developers:
- Gretchen Foltz, MD- Washington University – St Louis
- Abigail Mills, MD- Washington University – St Louis
- Francisco Gortes, MD- Washington University – St Louis

Facebook
X
LinkedIn
Forward